Manila Times Business
Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
Peer-reviewed journal Clinical Chemistry published the first head-to-head study comparing GraftAssure™ to industry-leading competitorGraftAssure’s industry-leading reference change value (time-point to time-point change) supports transplanted organ health screening and rejection recurrence monitoring NASHVILLE, Tenn., June 16, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX) ("iMDx") today announced the online publication of a favorable article in Clinical Chemistry, t
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Bookies.com Updates UK Apple Pay Casinos Guide to Reflect New UKGC Wagering Rules and Bonus Restrictions
2h ago
Falco’s Horne 5 Project: The Government of Québec confirms the project's progress within its environmental authorization process
2h ago
Element Plumbing, Heating, Air & Electrical Named Best Plumber in 2026 Best of Southern Utah Awards
2h ago
SIP, STYLE, TRAVEL, & SUNSHINE: THE SUMMER VIBES TAKING OVER 2026 in Discussion with YourUpdateTV
2h ago